Nanostics


Nanostics is a health technology company focused on developing innovative diagnostic solutions, particularly for prostate cancer detection and management. They are engaged in clinical validation studies and collaborations to improve early diagnosis and treatment options.

Industries

biotechnology
health-care

Nr. of Employees

small (1-50)

Nanostics

Edmonton, Alberta, Canada, North America


Products

Prostate diagnostic blood test (clinical validation ongoing)

A blood-based diagnostic intended to predict clinically significant prostate cancer and function as a reflex or triage test to reduce unnecessary biopsies.

Predictive research online system for prostate cancer tasks

A web-based platform to support predictive research tasks and workflows related to prostate cancer studies.


Services

Clinical validation and trial management for diagnostics

Design and conduct of clinical validation and pivotal studies for diagnostic assays, including participant recruitment and trial execution.

Analytical validation and performance qualification for microflow cytometers

Technical evaluation and performance qualification services for microflow cytometers and related assay workflows.

AI/GPU-based cellular analysis services

High-performance computing services for cellular data analysis to support diagnostic interpretation and research.

Expertise Areas

  • Clinical trial management and recruitment
  • Diagnostic biomarker development
  • Assay validation and performance qualification
  • Microflow cytometry
  • Show More (4)

Key Technologies

  • Microflow cytometry
  • Nanotechnology-based assay methods
  • GPU-accelerated image and cellular analysis
  • Machine learning for diagnostics
  • Show More (3)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.